Jama Pitman
Corporate Officer/Principal bei DECIPHERA PHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Jama Pitman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2015 | - |
| General Counsel | 01.01.2015 | - |
Karriereverlauf von Jama Pitman
Ausbildung von Jama Pitman
| University of New Hampshire | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Jama Pitman
- Erfahrung